Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NextGen Biomed Ltd. Report Publication Announcement 2024

Jun 30, 2024

6949_rns_2024-06-30_b30dbece-3b9a-4f80-9c03-543d0817def1.pdf

Report Publication Announcement

Open in viewer

Opens in your device viewer

June 30, 2024 443836.docx

==> picture [111 x 87] intentionally omitted <==

To: TASE Members

Dear Sir/Madam,

Re: NEXTGEN BIOMED LTD- renewal of trading

1.Trading in the company's shares was suspended on May 1, 2024, since the company did not publish its financial statements for the year ended on December 31, 2023.

  1. On June 27, 2024, the company published the aforementioned financial statements. Therefore, trading in the company's shares (ISIN IL0010839301) will be renewed on

Tuesday, July 2, 2024, on the main list.

==> picture [459 x 82] intentionally omitted <==

Sincerely,

(-)

Listing companies' compliance unit

==> picture [385 x 58] intentionally omitted <==